Pulmonary metabolism of biogenic amines

Comprehensive Therapy

Volumn 23, Issue 4, 1997, Pages 254-258

  Akber, Syed Farooq ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOGENIC AMINE;

ADULT RESPIRATORY DISTRESS SYNDROME; CIGARETTE SMOKING; HUMAN; LUNG ENDOTHELIUM; LUNG INJURY; LUNG TUBERCULOSIS; METABOLISM; REVIEW;

ANIMALS; BIOGENIC AMINES; DOGS; ENDOTHELIUM; HUMANS; LUNG; RESPIRATORY DISTRESS SYNDROME, ADULT; SENSITIVITY AND SPECIFICITY; SMOKING; TUBERCULOSIS;

EID: 0030999291     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Lefkowitz R, Caron MG, Stiles GL. Mechanisms of membrane-receptor regulation: biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors. N Engl J Med. 1984;310:1570-1579.
2. Syrota A, Pascal O, Crouzel M, Kellershohn C. Pulmonary extraction of C-11 chlorpromazine, measured by residue detection in man. J Nucl Med. 1981;22:145-148.
3. Gillis CN, Cronau LH, Mandel S, Hammond GL. Indicator dilution measurement of 5 HT clearance by human lung. J Appl Physiol. 1979;46:1178-1183.
4. Anderson MW, Orton TC, Pichett RD, Eling TE. Accumulation of amines in the isolated perfused rabbit lung. J Pharmac Exp Ther. 1976;189:456-466.
5. Dollery CT, Junod PJ. Concentration of (±) propranolol in isolated, perfused lungs of rat. Br J Pharmac. 1976;57:67-71.
6. Youdim MBH. Inactivation of monoamines by the lung. In: Metabolic Activities of the Lung. Ciba Foundation Symposium 78, New Series. Excerpta Medica. 1980:105-128.
7. Whitecomb ME. Pulmonary Edema: The Lung Normal and Diseases. St. Louis, MO: C.V. Mosby; 1982.
8. Ryan US, Ryan JW, Whitaker C, Chiu A. Localization of angiotension converting enzyme (Kininase II). II: immuno-cytochemistry and immunofluorescence. Tissue Cell. 1976;8:125.
9. Ryan JW, Roberlo J, Stewart JM. Inactivation of bradykinin in the pulmonary circulation. Biochem J. 1968;110:795.
10. Drew G, Nicholls PJ. Uptake of amphetamine by guinea-pig lung in vitro. J Pharm Pharmacol. 1978;30(suppl):55. Proceedings.
11. Orton TC, Anderson MW, Pickett RD, Eling TE, Fouts JR. Xenobiotic accumulation and metabolism by isolated perfused rabbit lungs. J Pharmacol Exp Ther. 1973;186:482-497.
12. Lin TH, Mar BM, Wu JL, Baldwin RM, Lomb JF. Brain localization and octanol/water PC-pH profiles of radioiodinated amines: evidence against "pH Shift." J Nucl Med. 1984;25:122.
13. Gallagher BM, Fowler JS, Macgregor RR, et al. In vivo measurement of transport and metabolic processes using radiotracers. In: Colombetti LG, ed. Principles of Radiopharmacology. Vol II Boca Raton, FL: CRC Press; 1979;135-154.
14. Akber SF. Pulmonary biogenic amines uptake mechanism: is it dependent on pH, lipophilicity or pka? Nuclear Med. 1991;30:294-296.
15. Block ER, Fisher AB. Depression of serotonin clearance by rat lungs during oxygen exposure. J Appl Physiol. 1977;42:33-38.
16. Chinard FP, Enns T. Transcapillary pulmonary exchange of water in the dog. Am J Physiol. 1954;178:197-202.
17. Crone C. The permeability of capillaries in various organs as determined by use of the "indicator diffusion" method. Acta Physiol Scand. 1963;58:292-205.
18. Akber SF. Ketamine influence on the first pass pulmonary extraction of N-isopropyl-I-123-p-iodoamphetamine using indicator dilution technique. Proceedings at the XIV International Conference on Medical and Biochemical Engineering and the VII International Conference on Medical Physsiology, Medical and Biological Engineering and Computers. 1985;23(suppl): part 2, 1377-1378.
19. Rahimian J, Glass EC, Touya JJ, Akber SF, Graham LS, Bennett LR. Measurement of metabolic extraction of tracers in the lung using multiple indicator kilution technique. J Nucl Med. 1984;25:31-37.
20. Akber SF. Demonstration and quantitation of pharmacological inhibition of pulmonary uptake of N-isopropyl-I-123-p-iodoamphetamine by propranolol. Nucl Med. 1989;28:100-104.
21. Rowland RRR, Yamzquchi KT, Santibanez AS, Kodama KT, Ness VT, Grubbs DE. Smoke inhalation model for lung permeability studies. J Trauma. 1986;26:153-156.
22. Suga K, Ariyoshi I, Nakanishi T, Utsumi H, Yamada N. Clinical and experimental studies on the mechanism of abnormal accumulation in lung scanning with I-123-IMP. Nuc Med Commun. 1992;13:33-40.
23. Gillis CN, Catravas JD. Altered removal of vasoactive substances in the injured lung: detection of lung micro vascular injury. Ann NY Acad Sci. 1982;384:458-474.
24. Geddes DM, Nesbitt K, Trail T, Blackbuen IP. First pass uptake of C-14 propranolol by the lung. Thorax. 1979;34:810.
25. Touya JJ, Rahimian J, Grubbs DE, Corbus HF, Bennett LR. A noninvasive procedure for in vivo assay of a living amine endothelial receptor. J Nucl Med. 1985;26:1302.
26. Akber SF. A noninvasive assessment of pharmacological interaction of amines in the lung. Nuc Med Commun. 1987;8:890-893.
27. Connors AF, McCaffee DR, Rogers RM. The ARDS. DM. 1981;27:1-75.
28. Fowler AA, Baird M, Eberle N, et al. Attack: rates and mortality of the adult respiratory distress syndrome in patients with predisposition abstracted. Ann Rev Respir Dis. 1983;125:77.
29. Gillis CM, Pitt RB. Depressed prostglandin E, and 5 HT removal in patients with adult respiratory distress. Ann Rev Respir Dis. 1986;134:739-744.
30. Nagamachi S, Inoue K, Hoshi H, et al. Lung scintigraphy with I-123-IMP in patients with pulmonary tuberculosis. Nuc Med Biol. 1992;19:399-404.
31. Ishino Y, Nakata H. 123-I-IMP clearance of the lung in pneumoconiosis. Kaku-Igaku. 1994;31:921-926.
32. Kato K, Harada S, Takahashi T, Katsuragawa S, Yanagisawa T. Effects of cigarette smoking on iodine 123 N-Isopropropyl-p-iodoamphetamine clearance from the lung. Eur J Nucl Med. 1991;18:801-805.